Sep 04, 2019 / 02:15PM GMT
Unidentified Analyst -
The future looks like peering into the crystal ball, so to speak. So we have with us pretty distinguished guests from REGENXBIO, the CEO, Ken Mills; from Ultragenyx on my right here, Sam Wadsworth, the SVP and CSO of Gene Therapy Research & Development; and from uniQure, Matt Kapusta, the CEO of the company. So welcome, all of you.
Questions and Answers:
Unidentified Analyst -And maybe to kick it off, I think it will be great to get your high-level views on your thoughts about how to build a gene manufacturing commercial-scale organization. What is needed to make gene therapy manufacturing successful? What are the ingredients? So what are the dos and the don'ts, so to speak, or the rules of the road to get to successful products. So want to kick it off, Matt?
Matthew Craig Kapusta - uniQure N.V. - CEO, Interim CFO & Executive Director
Sure. Yes. We do know a thing or 2 about that because we spent the last, 10, 15 years doing exactly that. And obviously, one of the things you need is a whole lot
Trustpilot
